These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of nitric oxide in the autoregulation of renal blood flow and glomerular filtration rate in aging spontaneously hypertensive rats. Kvam FI; Ofstad J; Iversen BM Kidney Blood Press Res; 2000; 23(6):376-84. PubMed ID: 11070417 [TBL] [Abstract][Full Text] [Related]
3. Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans. Dijkhorst-Oei LT; Boer P; Rabelink TJ; Koomans HA J Am Soc Nephrol; 2000 Jul; 11(7):1293-1302. PubMed ID: 10864586 [TBL] [Abstract][Full Text] [Related]
4. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension. Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876 [TBL] [Abstract][Full Text] [Related]
5. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Millar CG; Thiemermann C Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-(1-7)-induced renal vasodilation is reduced in human kidneys with renal artery stenosis. Van Twist DJ; Houben AJ; De Haan MW; Mostard GJ; De Leeuw PW; Kroon AA J Hypertens; 2014 Dec; 32(12):2428-32; discussion 2432. PubMed ID: 25208127 [TBL] [Abstract][Full Text] [Related]
7. Assessment of endothelial function of the renal vasculature in human subjects. Delles C; Jacobi J; Schlaich MP; John S; Schmieder RE Am J Hypertens; 2002 Jan; 15(1 Pt 1):3-9. PubMed ID: 11824856 [TBL] [Abstract][Full Text] [Related]
8. Nitric oxide affects angiotensin II pressor response: possible mechanism of attenuated pressor response during pregnancy and etiology of pregnancy-induced hypertension. Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H Gynecol Obstet Invest; 2000; 49(2):84-7. PubMed ID: 10671813 [TBL] [Abstract][Full Text] [Related]
9. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329 [TBL] [Abstract][Full Text] [Related]
10. Renal extraction of atrial natriuretic peptide in hypertensive patients with or without renal artery stenosis. Schreij G; van Es PN; Schiffers PM; de Leeuw PW Hypertension; 1996 Jun; 27(6):1254-8. PubMed ID: 8641732 [TBL] [Abstract][Full Text] [Related]
11. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats. Granstam SO; Lind L; Granstam E; Fellström B Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):693-701. PubMed ID: 9750958 [TBL] [Abstract][Full Text] [Related]
13. Divergent effects of ACE-inhibition and calcium channel blockade on NO-activity in systemic and renal circulation in essential hypertension. Dijkhorst-Oei LT; Beutler JJ; Stroes ES; Koomans HA; Rabelink TJ Cardiovasc Res; 1998 Nov; 40(2):402-9. PubMed ID: 9893735 [TBL] [Abstract][Full Text] [Related]
14. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. Shiode N; Morishima N; Nakayama K; Yamagata T; Matsuura H; Kajiyama G J Am Coll Cardiol; 1996 Feb; 27(2):304-10. PubMed ID: 8557898 [TBL] [Abstract][Full Text] [Related]
15. Forearm blood flow responses to a nitric oxide synthase inhibitor in patients with treated essential hypertension. Calver A; Collier J; Vallance P Cardiovasc Res; 1994 Nov; 28(11):1720-5. PubMed ID: 7531114 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of adenosine-induced renal vasodilatation in hypertensive patients. Wierema TK; Houben AJ; Kroon AA; Postma CT; Koster D; van Engelshoven JM; Smits P; de Leeuw PW J Hypertens; 2005 Sep; 23(9):1731-6. PubMed ID: 16093919 [TBL] [Abstract][Full Text] [Related]
17. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension. Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753 [TBL] [Abstract][Full Text] [Related]
18. Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: the role of nitric oxide. Felsen D; Schulsinger D; Gross SS; Kim FY; Marion D; Vaughan ED J Urol; 2003 Jan; 169(1):373-6. PubMed ID: 12478193 [TBL] [Abstract][Full Text] [Related]
19. Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat. Chin SY; Wang CT; Majid DS; Navar LG Am J Physiol; 1998 May; 274(5):F876-82. PubMed ID: 9612324 [TBL] [Abstract][Full Text] [Related]
20. Oxygen consumption in the kidney: effects of nitric oxide synthase isoforms and angiotensin II. Deng A; Miracle CM; Suarez JM; Lortie M; Satriano J; Thomson SC; Munger KA; Blantz RC Kidney Int; 2005 Aug; 68(2):723-30. PubMed ID: 16014049 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]